【レポートの概要(一部)】
1. Report Overview
1.1 Global Market Overview of the Renal Cancer Treatment Market
1.2 Benefits of This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methods of the Study
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. An Introduction to Renal Cancer Treatments
2.1 What is Renal Cancer?
2.2 Renal Cancer Drug Treatments
2.3 Defining the Renal Cancer Treatment Market
3. Leading Renal Cancer Drugs and Leading Companies: Profiles and Forecasts from 2015-2025
3.1 Angiogenesis Inhibitors Lead the Market
3.1.1 Sutent (sunitinib) – Pfizer
3.1.2 Nexavar (sorafenib) – Bayer/Onyx
3.1.3 Votrient (pazopanib) – Novartis
3.1.4 Inlyta (axitinib) – Pfizer
3.2 mTOR Inhibitors Are Strong Competitors
3.2.1 Afinitor/Votubia (everolimus) – Novartis
3.2.2 Torisel (temsirolimus) – Pfizer
3.3 Monoclonal Antibodies: One Drug Makes a Difference
3.3.1 Avastin (bevacizumab) – Roche
3.4 Immunotherapies: A Market to Watch
3.4.1 Proleukin (aldesleukin) – Novartis/Prometheus Laboratories
3.5 Leading Companies in the Renal Drug Treatment Market
3.5.1 Pfizer: Current Market Leader
3.5.2 Novartis: Building Up Strengths
3.5.3 Roche: Expanding Blockbuster Avastin
3.5.4 Bayer Healthcare and Onyx Pharmaceuticals
3.5.5 Other Companies of Interest
3.5.5.1 Exelixis, Bristol-Myers Squibb, Merck and Cerulean Pharma
4. Anti-Cancer Renal Treatments: World Market Outlook and Forecast 2015-2025
4.1 The World Market for Renal Cancer Treatments in 2014
4.2 Leading Renal Cancer Drug Treatments in 2014
4.3 World Revenue Forecasts 2015-2025: Changing Market Shares for the Renal Cancer Treatment Market
4.4 Leading Anti-Cancer Renal Treatment Submarkets 2015-2025
4.4.1 Angiogenesis Inhibitors Lead the Current Market
4.4.2 Monoclonal Antibodies: Avastin is a Strong Competitor
4.4.3 An Important Submarket: mTOR Inhibitors
4.4.4 Summary: Angiogenesis Inhibitors and mTOR Inhibitors Lead the Market in 2015
4.5 Drivers and Restraints of the Renal Cancer Treatment Market 2015-2025
4.5.1 Drivers of the Renal Cancer Treatment Market
4.5.2 Restraints of the Renal Cancer Treatment Market
5. Leading National Markets for the Renal Cancer Treatment Market 2015-2025
5.1 Regional Breakdown of the World Renal Cancer Treatment Market 2014
5.2 World Renal Cancer Treatment Market: Regional Forecasts 2015-2025
5.2.1 How Will Regional Market Shares Change to 2025?
5.3 The US Renal Cancer Treatment Market 2015-2025
5.3.1 The US Renal Cancer Treatment Market: Drivers and Restraints
5.4 The EU Renal Cancer Treatment Market 2015-2025
5.4.1 The Renal Cancer Treatment Market in Germany to 2025
5.4.2 The Renal Cancer Treatment Market in France to 2025
5.4.3 The Renal Cancer Treatment Market in Italy to 2025
5.4.4 The Renal Cancer Treatment Market in the UK to 2025
5.4.5 The Renal Cancer Treatment Market in Spain to 2025
5.5 The Japanese Renal Cancer Treatment Market
5.6 The Renal Cancer Treatment Market in the Emerging Market: BRIC Market Forecast 2015-2025
5.6.1 The Renal Cancer Treatment Market in China to 2025
5.6.2 The Renal Cancer Treatment Market in Brazil to 2025
5.6.3 The Renal Cancer Treatment Market in Russia to 2025
5.6.4 The Renal Cancer Treatment Market in India to 2025
6. Renal Cancer Drugs Industry: R&D Pipeline Analysis
6.1 Targeted Therapies in Development for the Treatment of Renal Cancer
6.1.1 Lenvima (lenvatinib) – Eisai Inc
6.1.2 Cometriq (cabozantinib) – Exelixis
6.1.3 Dovitinib (TKI258) – Novartis
6.1.4 Linifanib (ABT-869) – Abbott Laboratories
6.1.5 Tivozanib – Aveo Pharmaceuticals
6.1.6 BEZ235 – Novartis
6.1.7 Tivantinib (ARQ197) – Daiichi Sankyo/ArQule
6.1.8 Cediranib (AZD2171/Recentin) – AstraZeneca
6.2 Immunotherapies in Development for the Treatment of Renal Cancer
6.2.1 Opdivo (nivolumab) – Bristol-Myers Squibb
6.2.2 AGS-003 – Argos Therapeutics
6.2.3 IMA901- Immatics Biotechnologies/Roche
6.2.4 TVI-Kidney-1 – TVAX Biomedical
6.2.5 Keytruda (pembrolizumab/MK3475) – Merck & Co
6.2.6 Atezolizumab (MPDL3280A) – Roche
6.2.7 Avelumab (MSB0010718C) – Merck
6.3 Monoclonal Antibody Therapies in Development for the Treatment of Renal Cancer
6.3.1 TRC105 – Tracon Pharma
6.3.2 RENCAREX (girentuximab) – WILEX AG
6.3.3 Varlilumab (CDX-1127/ Anti-CD27) – Celldex Therapeutics
6.3.4 ASONEP (sonepcizumab/LT1009) – Lpath Inc
6.4 Novel Anti-Cancer Therapies in the Pipeline for Renal Cancer
6.4.1 CRLX101 – Cerulean Pharma
6.4.2 Entinostat (SNDX-275/MS-275) – Syndax Pharmaceuticals
7. Qualitative Analysis of the Renal Cancer Treatments Market, 2015-2025
7.1 SWOT Analysis of the Renal Cancer Treatment Market
7.1.1 Strengths and Weaknesses of the Market
7.1.2 The Increasing Prevalence of Renal Cancer
7.1.3 A Rise in Ageing Population
7.1.4 Increasing Risk Factors: Obesity and Smoking
7.1.5 The High Cost of Drug Treatments Will Limit Market Growth
7.1.6 Important Patent Expiries Are Looming
7.2 Opportunities and Threats
7.2.1 Novel Therapies: The Rise of Immunotherapy
7.2.2 Combination Therapies: An Opportunity to Improve on Existing Treatments
7.2.3 Regulations: A Hindrance for Growth of the Market
8. Research Interviews
8.1 Interview with Dr Paul Bevan, Head of R&D, WILEX, Munich, Germany
8.1.1 RENCAREX: Possible First Adjuvant Treatment of RCC
8.2 Interview with Gary Wood, PhD, Chief Science Officer, TVAX Biomedical, Kansas, USA
8.2.1 Novel Immunotherapy Treatment for Renal Cancer
8.2.2 The Challenges of Using New Therapies
9. Conclusions
9.1 The Renal Cancer Treatment Market: World Outlook from 2015
9.2 Growth Will Be Driven by an Increase in Demand
9.3 The Global Renal Cancer Treatment Market Will Continue to be Dominated by the US and the EU
9.4 Leading Renal Cancer Treatment Drug Companies
9.5 The Future of the Renal Cancer Treatment Market
【レポート販売概要】
■ タイトル:腎臓がん治療の世界市場動向及び予測■ 英文:Renal Cancer Treatment: Industry Analysis, R&D Trends and World Market Forecasts 2015-2025
■ 発行日:2015年10月
■ 調査会社:visiongain
■ 商品コード:VGAIN5102609
■ 調査対象地域:グローバル
- 構造用接着剤の世界市場:建物・建設用、バス・トラック用、自動車用、航空用、船舶用、風力エネルギー用接着剤The global structural adhesives market is projected to reach USD 12.74 Billion by 2021, registering a CAGR of 6.9% between 2016 and 2021. The demand for structural adhesives is increasing for bonding high-performance components and reducing weight. High use of adhesives helps to reduce the weight of components and will help meet the mega trend of reducing CO2 emissions and increasing efficiency. T …
- コンクリート表面処理用化学薬品の世界市場2019-2023Global Concrete Surface Treatment Chemicals Market: About this market Technavio’s concrete surface treatment chemicals market analysis considers sales to non-residential and residential segments. Our analysis also considers the sales of concrete surface treatment chemicals in APAC, Europe, MEA, North America, and South America. In 2018, the non-residential segment held the highest market share, wh …
- 世界の構造化データ管理ソフトウェア市場:リレーショナルデータベース管理システム(RDMS)、 データ統合/アクセスソフトウェア等About Structured Data Management Software Structured data management software is used to store and manage various forms of data generated by companies. It is also an approach to manage the flow of data through the entire cycle (from creation of the data to the time it is deleted) in organizations. Recently, the need for the effective management of corporate data has increased widely due to growing …
- 世界の政府部門におけるバイオメトリクス(生体認証)市場About Biometrics Biometrics involves the authentication of an individual by evaluating one or more unique biological traits. This authentication can be done through voice recognition, hand geometry analysis, DNA analysis, gait recognition, fingerprint identification, facial recognition, iris recognition, signature verification, and vein recognition. Biometric technologies are considered to be more …
- EOG Resources, Inc.:石油・ガスバリューチェーン分析レポート2013EOG Resources, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "EOG Resources, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “EOG Resources, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- 高調波フィルタの世界市場2018-2022116 pages, November 2018 About this market The rising investments in renewable energy to trend in the market. Resources available for industries across the world are limited as most government has imposed strict regulations to control the use of resources. Consumers are also motivated to use eco-friendly products. Technavio’s analysts have predicted that the harmonic filters market will register a …
- ポリウレタンの世界市場予測(~2021):原料別(ジフェニルメタンジイソシアネート(MDI)、トルエンジイソシアネート(TDI)、ポリオール)、製品別(コーティング、接着剤・密閉剤、軟質・硬質発泡体、エラストマー)、エンドユーザー別(ビル・建設、自動車・輸送、寝具・家具)“The global market for polyurethane is projected to grow at a CAGR of 5.6% from 2016 to 2021”The global polyurethane market is projected to reach USD 56.76 billion by 2021, at a CAGR of 5.6%, from 2016 to 2021. The growing middle class with increasing disposable incomes, and rising urbanization supplemented strongly by investments in infrastructure is driving the global polyurethane market. The ri …
- 動物用ワクチン(Veterinary vaccine)の世界市場機会分析Veterinary vaccines are a fast growing component of the overall animal health market which itself was worth approximately $24bn/yr in 2013. Key segments are vaccines for companion animals such as the canine and feline markets along with livestock, pigs and poultry. Veterinary vaccines are attractive commercially due to population growth and an increased demand for animal protein as a food source e …
- Beta-2 Microglobulin:医療検査市場2014The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
- ヘッドセットの世界市場分析:製品別(インイヤー、オーバーイヤー)、価格別(USD50未満、USD50~100、USD100以上)、技術別(ワイヤー式、ワイヤレス)、用途別(個人用、商業用)、セグメント予測The headsets market is estimated to reach approximately USD 20,465.7 million by 2024, according to a new study conducted by Grand View Research, Inc. The rise in the disposable income is remarkably driving the demand for application-specific headsets. The increase in consumer spending for consumer electronic products has significantly spurred the market growth. The growing demand for improved desi …
- 麻酔モニタリング装置の世界市場2017-2021ABSTRACTAbout anesthesia monitoring devices Anesthesia monitoring devices are used to measure the vital signs and depth of anesthesia during surgical procedures. These devices reduce the risks involved in surgery and check the individual’s response toward anesthesia during a surgical procedure. Technavio’s analysts forecast the global anesthesia monitoring devices market to grow at a CAGR of 5.05% …
- ステアリング装置の世界市場:EPS(電動パワーステアリング)、EHPS、HPS(油圧パワーステアリング)The steering system market size is projected to grow at a promising CAGR of 6.18% during the forecast period, to reach USD35.99 Billion by 2020. The recent increase in demand for automobiles in the U.S. and Mexico has confirmed that the North American automotive industry has begun its recovery phase and according to industry experts, the market is projected to continue with a similar growth trend …
- アイスクリーム食品市場:マルタ(~2017)Synopsis "Ice Cream Market in Malta: Databook to 2017" is the result of Canadean's extensive market research covering the Ice Cream market in Malta. The report presents detailed historic and forecast data on the Ice Cream consumption trends in Malta, offering consumption volume and value at market and category level. Bringing together Canadean's research, modeling, and analysis expertise to develo …
- ビタミン成分の世界市場:ビタミンB、ビタミンC、ビタミンK、ビタミンD、ビタミンE、ビタミンAAbout Vitamins Vitamins are organic compounds that are required by living organisms in minute quantities to maintain a normal metabolic activity. These compounds usually cannot be synthesized by the organism and have to be obtained through external sources. The term “vitamin” is a generic descriptor for a group of chemical compounds or ingredients that have similar molecular structure and have the …
- 医療機器業界のM&A及び投資動向(四半期別):Q2 2013Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2013 Summary GlobalData’s “Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2013” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private eq …